Arnett Cancer Care

420 North 26th Street - Lafayette, IN 47904

For information about clinical trials being conducted in Lafayette, IN, please contact Janice Welty, RN at 765.448.7536.

Thomas I. Jones, MD (Principal Investigator)

Trials at this Location:

Disease: Banking / Biorepository
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies - BNK09-138
Status: Open to Accrual 10-06-2009; 124 of 200 accrued.
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic - BRE-126
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 21 of 44 accrued.
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study - DoD COE-01
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 09-27-2005 - 76 of 133 Patients Accrued
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative - DoD COE-03 (BRE-126)
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 21 of 44 accrued.
More Details

Disease: Lung
A Randomized Double Blind Phase II Trial of Cisplatin plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer - LUN06-113
Status: Open to Accrual - 01-23-2008 - 35 of 74 Patients Accrued
More Details